Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| NALLS SHERBAKOFF GROUP LLC | 03-21-2024 | 12-31-2023 | 460 | 112,334,842 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| ENDAVA PLC | ADS | 501 | $468 | 6 | 0.00 | 0.00 | -6 | -50.00 | 12-31-2023 |
| CALLIDITAS THERAPEUTICS AB | SPONSERED ADS | 502 | $464 | 18 | 0.00 | 0.00 | -17 | -48.57 | 12-31-2023 |
| CRISPR THERAPEUTICS AG | NAMEN AKT | 503 | $439 | 7 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| RESIDEO TECHNOLOGIES INC | COM | 504 | $433 | 23 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
